|
⚲
|
| Keyboard |
| Chen Bihua
✚
|
|
|---|---|
| CIK # | 0001599214 |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Praxis Precision Medicines Inc | 0.3 | ||
| Helix Acquisition Corp II | 0.2 | ||
| Psivida Corp | 0.1 | ||
| Edgewise Therapeutics Inc | 0.1 | ||
| Erasca Inc | 0.1 | ||
| Rapport Therapeutics Inc | 0.1 | ||
| Alumis Inc | 0.1 | ||
| Abivax Sa | 0.1 | ||
| Helix Acquisition Corp | 0.1 | ||
| Magenta Therapeutics Inc | 0.1 | ||
| View All | |||
| Holdings by Sector ($B) |
|---|
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-NT | [0001599214] | |
| 3 | [0001599214] | |
| 4 | [0001599214] | |
| SC 13G | [0001599214] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Chen Bihua | Moonlake Immunotherapeutics | [2023-03-31] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Helix Acquisition Corp III HLXC
Class A Ordinary Shares
|
2026-01-26 | Grant | 497,500 | $10.00 | 4,975,000 |
|
Helix Acquisition Corp III HLXC
Class B Ordinary Shares · derivative
|
2026-01-22 | Other | 718,750 | ||
|
Corbus Pharmaceuticals Holdings Inc CRBP
Common Stock
|
2025-12-11 | Sell | 30,029 | $11.46 | 344,132 |
|
EyePoint Inc EYPT
Common Stock
|
2025-12-04 | Sell | 60,000 | $15.70 | 942,000 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-30 | Sell | 5,827 | $6.96 | 40,556 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 3,390,943 | $7.58 | 25,703,348 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 70,748 | $9.38 | 663,616 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 232,460 | $8.40 | 1,952,664 |
|
MoonLake Immunotherapeutics MLTX
Class A Ordinary Shares
|
2025-09-29 | Sell | 2,800,000 | $6.61 | 18,508,000 |
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Option exercise | 4,172,126 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 1,905,046 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Disposed to issuer | 152,940 | $0.00 | |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Option exercise | 4,172,126 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 760,496 | $10.72 | 8,152,517 |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 284,571 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 1,762,760 | ||
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 5,598,425 | $10.72 | 60,015,116 |
|
BridgeBio Oncology Therapeutics Inc BBOT
Common Stock
|
2025-08-11 | Grant | 639,110 | $10.72 | 6,851,259 |
|
BridgeBio Oncology Therapeutics Inc BBOT
Class B ordinary shares · derivative
|
2025-08-11 | Disposed to issuer | 307,874 | $0.00 | |
|
Biomea Fusion Inc BMEA
Stock Option (Right to Buy) · derivative
|
2025-06-11 | Grant | 91,970 | $0.00 | |
| showing 20 of 200 most recent transactions | |||||